Patient Safety

Safety & Regulation

Your safety is our highest priority. Learn about eligibility criteria, potential risks, regulatory context, and our commitment to responsible clinical practice.

Discuss Your Eligibility

Medical Disclaimer

The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.

Who May Benefit

Eligibility Criteria

Not everyone is a suitable candidate for stem cell therapy. We conduct thorough assessments to determine whether treatment may be appropriate for each individual. The following general criteria help guide our eligibility evaluation.

May Be Suitable If You:

Have a diagnosed condition that may respond to regenerative therapy
Have tried conventional treatments with insufficient results
Are in generally stable overall health
Have realistic expectations about potential outcomes
Can commit to the recommended follow-up programme
Do not have active infections or certain contraindications

May Not Be Suitable If You:

Have an active systemic or localised infection
Have active or recently treated malignancy
Are pregnant or planning pregnancy
Have severe, end-stage organ failure
Have certain blood disorders or coagulation issues
Are seeking a guaranteed cure or immediate results

Important Considerations

Contraindications

The following conditions are generally considered contraindications for stem cell therapy. Each case is evaluated individually, and some conditions may be relative rather than absolute contraindications.

Active cancer or malignancy
Active systemic infection (bacterial, viral, fungal)
Severe uncontrolled diabetes
Active autoimmune flare requiring acute intervention
Pregnancy or breastfeeding
Severe blood disorders or coagulopathies
Uncontrolled cardiovascular disease
Recent organ transplant or immunosuppression
Active substance abuse
Severe psychiatric conditions affecting consent capacity

This list is not exhaustive. Our clinical team conducts a comprehensive evaluation to identify any factors that may affect treatment suitability or safety.

Choosing Wisely

What Responsible Clinics Offer

When evaluating stem cell therapy providers, patients should look for clinics that demonstrate these hallmarks of responsible clinical practice.

Thorough Screening

Comprehensive pre-treatment assessment including medical history review, clinical examination, and diagnostic imaging. Willingness to decline treatment for unsuitable candidates.

Informed Consent

Clear explanation of the treatment process, potential benefits, limitations, risks, and alternative options. Written consent obtained before any procedure.

Qualified Clinicians

Board-certified physicians with relevant specialisation and demonstrated experience in regenerative medicine. Ongoing professional development and training.

Transparent Pricing

Full cost disclosure before treatment commitment. No hidden fees, no pressure tactics, and no obligation to proceed after consultation.

Realistic Expectations

Honest communication about what stem cell therapy can and cannot achieve. No guarantees of cure or specific outcomes. Acknowledgement that results vary between individuals.

Structured Follow-Up

Defined follow-up programme to monitor progress. Ongoing clinical support and availability for questions or concerns after treatment.

Why Boston Health Longevity

Our safety commitment in practice

At Boston Health Longevity, patient safety is not a marketing statement. It is embedded in every clinical decision, led by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of medical experience.

We Turn Patients Away

Not everyone is a candidate. We decline patients who are unlikely to benefit or who present significant risk factors. This honest screening is a hallmark of responsible practice that protects both our patients and our clinical reputation.

GMP-Certified Cell Supply

All umbilical cord-derived mesenchymal stem cells are sourced exclusively from GMP-certified partner laboratories. Every batch undergoes sterility testing, viability assays, endotoxin screening, and flow cytometry verification before clinical use.

12-Month Follow-Up Protocol

We maintain structured follow-up at 1, 3, 6, and 12 months post-treatment. This long-term monitoring tracks outcomes, identifies any concerns early, and allows protocol adjustments when needed.

Clinician-Led, Not Sales-Led

Treatment recommendations are made by qualified physicians, not patient coordinators or sales teams. Dr Ackland sets all medical protocols and training. Our on-site Medical Lead, Dr Ploy, oversees day-to-day clinical operations in Chiang Mai.

Questions About Safety or Eligibility?

Our clinical team is available to discuss your specific situation and help determine whether stem cell therapy may be appropriate for you.

Discuss Your Eligibility

Transparency

Potential Risks

As with any medical procedure, stem cell therapy carries potential risks. We believe in complete transparency about these risks so patients can make fully informed decisions.

Known Potential Risks Include:

Injection site reactions: Temporary pain, swelling, or bruising at the injection site. Usually resolves within a few days.
Infection: Small risk of infection at injection sites. Minimised through strict sterile protocols and GMP-certified cell preparation.
Allergic reactions: Rare possibility of reaction to materials used in cell processing. Pre-treatment screening helps identify susceptible individuals.
Temporary symptom flare: Some patients experience a temporary increase in symptoms before improvement. This is usually short-lived.
Treatment failure: Not all patients respond to stem cell therapy. Results vary and cannot be guaranteed.
Rare serious events: Although uncommon, more serious adverse events have been reported in the medical literature. These are discussed during the informed consent process.

Regulatory Context

Regulatory Landscape

The regulatory environment for regenerative medicine is evolving globally. We believe in providing patients with an honest assessment of the current regulatory context to support informed decision-making.

Thailand's Regulatory Framework

Thailand's healthcare sector is overseen by the Ministry of Public Health, Thai FDA, and the Medical Council of Thailand. The regulatory framework for regenerative medicine continues to develop as the field advances. We operate within applicable guidelines and maintain the clinical standards expected of medical practitioners in Thailand.

Global Regulatory Context

Regulatory approaches to stem cell therapy vary significantly between countries. Some jurisdictions have established specific frameworks, while others are still developing their regulatory positions. Patients should be aware that stem cell therapies may not have the same regulatory approval status in Thailand as treatments approved by bodies such as the FDA (US), TGA (Australia), or EMA (Europe).

Our Standards

Our Compliance Commitment

We hold ourselves to high clinical and ethical standards. Our commitment to compliance and responsible practice includes:

All clinicians are registered and licenced medical practitioners in Thailand
Strict adherence to sterile processing and clinical protocols
Comprehensive informed consent process for every patient
Detailed medical record keeping and treatment documentation
Regular clinical audits and quality assurance reviews
Transparent communication about treatment limitations and realistic outcomes
No misleading claims about cure rates or guaranteed results
Ongoing monitoring of adverse events and clinical outcomes
Professional indemnity insurance for all practising clinicians
Commitment to patient data privacy and confidentiality

Our Treatment Services Contact Our Team

Medical Disclaimer

Common Questions

Safety FAQs

Answers to frequently asked questions about the safety and regulation of stem cell therapy.

Is stem cell therapy safe?

When performed by qualified clinicians using established protocols and proper screening, stem cell therapy has a generally favourable safety profile. However, as with any medical procedure, there are risks. We conduct thorough pre-treatment assessments to minimise these risks and discuss them openly with every patient.

What are the most common side effects?

The most common side effects include temporary soreness or swelling at the injection site, mild bruising, and short-term fatigue. These typically resolve within a few days. More serious adverse events are rare but are discussed thoroughly during the informed consent process.

How do I know if a clinic is reputable?

At Boston Health Longevity, we offer thorough pre-treatment assessment, honest eligibility screening (we turn away unsuitable candidates), transparent pricing, qualified medical professionals, and no guarantees about specific outcomes. We provide informed consent documentation and structured follow-up care.

Is stem cell therapy regulated in Thailand?

Thailand has a developing regulatory framework for regenerative medicine. The Thai FDA and Medical Council of Thailand provide oversight for medical practices. We operate within the applicable regulatory guidelines and maintain appropriate clinical standards. Patients should be aware that regulatory frameworks for regenerative medicine continue to evolve globally.

Can stem cell therapy cure my condition?

We do not claim that stem cell therapy can cure any condition. It is an emerging therapeutic approach that may support the body's natural repair processes and provide symptom relief in some patients. Outcomes vary between individuals and cannot be guaranteed. We provide realistic guidance about potential benefits and limitations.

What happens if the treatment does not work for me?

Not all patients respond to stem cell therapy. We set realistic expectations during the consultation process and discuss the possibility that treatment may not achieve the desired outcome. Our follow-up programme monitors your progress and our clinical team remains available to discuss alternative options if needed.

Do you screen patients before accepting them?

Yes. We conduct thorough eligibility screening for every patient. This includes reviewing medical history, current medications, imaging, and conducting clinical assessments. We will not proceed with treatment if we believe it is not appropriate for your condition or if significant contraindications are present.

What qualifications do your clinicians have?

Our clinical team consists of board-certified physicians with specialised training in regenerative medicine. Each clinician has years of experience in their respective specialties and ongoing professional development in the field of regenerative therapies.

Medical Disclaimer: Results vary between individuals and cannot be guaranteed. This information does not constitute medical advice. Consult a qualified healthcare provider before making treatment decisions.

Have Safety Questions?

Our clinical team welcomes your questions about safety, eligibility, and our clinical standards. No question is too small.

Ask Our Team